Approval · Notice of Compliance 26798 · 2021
DONEPEZIL: Notice of Compliance 26798
Issued October 5, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26798
- Date
- October 5, 2021
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ARICEPT (Pfizer Canada Ulc)
Products in this notice
Medicinal ingredients
- DONEPEZIL HYDROCHLORIDE 5 MG per TAB
- DONEPEZIL HYDROCHLORIDE 10 MG per TAB